- PMID 19491814.
Mikhaylova M,
Vakhitova JV,
Yamidanov RS,
Salimgareeva MK,
Seredenin SB,
Behnisch T (October 2007). "The
effects of
ladasten on dopaminergic...
- DVD-111; GVS 111;
Noopept Gudasheva TA,
Koliasnikova KN,
Antipova TA,
Seredenin SB (July 2016). "Neuropeptide
cycloprolylglycine increases the levels...
- 21
March 2015.
Neznamov GG,
Siuniakov SA,
Chumakov DV,
Bochkarev VK,
Seredenin SB (2001). "[Clinical
study of the
selective anxiolytic agent afobazol]"...
- p. 299. ISBN 9781477156995. Daugel'-Dauge NO,
Durnev AD,
Kulakova AV,
Seredenin SB, Velichkovskiĭ BT (1995). "[Corpuscular
mutagenesis and its prevention]"...
- PMID 6104993. Neznamov, GG; Siuniakov, SA; Chumakov, DV; Bochkarev, VK;
Seredenin, SB (2001). "Clinical
study of the
selective anxiolytic agent afobazol"...
- PMID 30187283.
Mikhaylova M,
Vakhitova JV,
Yamidanov RS,
Salimgareeva MK,
Seredenin SB,
Behnisch T (October 2007). "The
effects of
ladasten on dopaminergic...
-
range of doses.
Mokrov GV,
Deeva OA,
Gudasheva TA,
Yarkov SA,
Yarkova MA,
Seredenin SB (Jul 2015). "Design,
synthesis and anxiolytic-like
activity of 1-arylpyrrolo[1...
- PMID 22886028.
Gudasheva TA,
Grigoriev VV,
Koliasnikova KN,
Zamoyski VL,
Seredenin SB (November 2016). "Neuropeptide
cycloprolylglycine is an endogenous...
- S2CID 8469340. Gudasheva,
Tatiana A.; Povarnina,
Polina Y.; Tarasiuk,
Aleksey V.;
Seredenin,
Sergey B. (September 2021). "Low-molecular
mimetics of
nerve growth factor...
